Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   squamous cell carcinoma of head and neck
  

Disease ID 852
Disease squamous cell carcinoma of head and neck
Definition
A highly malignant neoplasm that can occur on the lip, oral cavity, nasal cavity, pharynx, larynx and paranasal sinuses and that accounts for 90% of all head and neck cancers, occurring most frequently in adults between the ages of 40-60. Presents with a variety of manifestations, depending on the primary site, such as voice hoarseness, dysphagia, ulceration of oral mucosa, hearing loss, epistaxis, nasal obstruction and enlargement of a cervical lymph node. Often associated with extensive invasion into surrounding tissues and a rapid metastasis to distant organs.
Synonym
carcinoma cell head neck squamous
carcinoma, squamous cell of head and neck
carcinomas cell head neck squamous
head and neck squamous cell carcinoma
head and neck squamous cell carcinoma, nos
hnscc
scchn
squamous cell cancer, head and neck
squamous cell carcinoma of head and neck (disorder)
squamous cell carcinoma of the head and neck
squamous cell carcinoma, head and neck
Orphanet
OMIM
DOID
UMLS
C1168401
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:38)
C0007137  |  squamous cell carcinoma  |  200
C0334246  |  metastatic squamous cell carcinoma  |  8
C0686619  |  lymph node metastases  |  6
C0011603  |  dermatitis  |  4
C0153676  |  lung metastasis  |  4
C0279626  |  esophageal squamous cell carcinoma  |  3
C0030354  |  papilloma  |  3
C0553723  |  cutaneous squamous cell carcinoma  |  2
C0153676  |  lung metastases  |  2
C1568868  |  oral mucositis  |  2
C0007137  |  squamous carcinoma  |  2
C0004096  |  asthma  |  1
C0028754  |  obesity  |  1
C2349952  |  oropharyngeal carcinoma  |  1
C0011570  |  depression  |  1
C0700251  |  brachial plexopathy  |  1
C0678222  |  breast carcinoma  |  1
C0242379  |  lung cancer  |  1
C0007115  |  thyroid ca  |  1
C0042769  |  virus infection  |  1
C0206720  |  squamous cell neopl  |  1
C0220650  |  brain metastases  |  1
C0151546  |  carcinoma of the oral cavity  |  1
C0019158  |  hepatitis  |  1
C0684249  |  lung carcinoma  |  1
C0007137  |  squamous cell carcinomas  |  1
C0042214  |  vaccinia  |  1
C0019196  |  hepatitis c  |  1
C0494165  |  liver metastasis  |  1
C1335437  |  plexopathy  |  1
C0035335  |  retinoblastoma  |  1
C0019348  |  herpes simplex  |  1
C0006625  |  cachexia  |  1
C0027819  |  neuroblastomas  |  1
C0162429  |  poor nutrition  |  1
C0014859  |  esophageal neoplasm  |  1
C0948265  |  metabolic syndrome  |  1
C0549473  |  thyroid carcinoma  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:29)
5243  |  ABCB1  |  CTD_human
1244  |  ABCC2  |  CTD_human
3814  |  KISS1  |  CTD_human
5728  |  PTEN  |  CLINVAR;CTD_human;GHR;ORPHANET;UNIPROT
540  |  ATP7B  |  CTD_human
1956  |  EGFR  |  CLINVAR
7157  |  TP53  |  CTD_human;GHR
9429  |  ABCG2  |  CTD_human
3265  |  HRAS  |  GHR
10397  |  NDRG1  |  CTD_human
1029  |  CDKN2A  |  CTD_human;GHR
6648  |  SOD2  |  CTD_human
4851  |  NOTCH1  |  GHR
2195  |  FAT1  |  GHR
3236  |  HOXD10  |  CTD_human
5290  |  PIK3CA  |  GHR
5743  |  PTGS2  |  CTD_human
4363  |  ABCC1  |  CTD_human
3237  |  HOXD11  |  CTD_human
841  |  CASP8  |  CTD_human
10413  |  YAP1  |  CTD_human
3202  |  HOXA5  |  CTD_human
8795  |  TNFRSF10B  |  CLINVAR;CTD_human;UNIPROT
3621  |  ING1  |  CLINVAR;CTD_human;ORPHANET;UNIPROT
54556  |  ING3  |  UNIPROT
6845  |  VAMP7  |  CTD_human
8900  |  CCNA1  |  CTD_human
407007  |  MIR222  |  CTD_human
282617  |  IFNL3  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:26)
7157  |  TP53  |  CIPHER;CTD_human
595  |  CCND1  |  CIPHER
1026  |  CDKN1A  |  CIPHER
1029  |  CDKN2A  |  CIPHER;CTD_human
7161  |  TP73  |  CIPHER
3814  |  KISS1  |  CTD_human
4363  |  ABCC1  |  CTD_human
1244  |  ABCC2  |  CTD_human
5243  |  ABCB1  |  CTD_human
3202  |  HOXA5  |  CTD_human
8795  |  TNFRSF10B  |  CTD_human
3621  |  ING1  |  CTD_human
6845  |  VAMP7  |  CTD_human
3237  |  HOXD11  |  CTD_human
10413  |  YAP1  |  CTD_human
9429  |  ABCG2  |  CTD_human
10397  |  NDRG1  |  CTD_human
8900  |  CCNA1  |  CTD_human
407007  |  MIR222  |  CTD_human
3236  |  HOXD10  |  CTD_human
540  |  ATP7B  |  CTD_human
5743  |  PTGS2  |  CTD_human
282617  |  IFNL3  |  CTD_human
5728  |  PTEN  |  CTD_human
6648  |  SOD2  |  CTD_human
841  |  CASP8  |  CTD_human
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:357)
1244  |  ABCC2  |  1.277  |  DISEASES
86  |  ACTL6A  |  1.159  |  DISEASES
131  |  ADH7  |  2.113  |  DISEASES
10551  |  AGR2  |  1.329  |  DISEASES
220  |  ALDH1A3  |  1.477  |  DISEASES
283  |  ANG  |  1  |  DISEASES
55107  |  ANO1  |  2.895  |  DISEASES
302  |  ANXA2  |  1.888  |  DISEASES
57584  |  ARHGAP21  |  2.436  |  DISEASES
64283  |  ARHGEF28  |  1.289  |  DISEASES
10123  |  ARL4C  |  1.245  |  DISEASES
10092  |  ARPC5  |  1.42  |  DISEASES
468  |  ATF4  |  1.19  |  DISEASES
489  |  ATP2A3  |  1.428  |  DISEASES
9334  |  B4GALT5  |  2.387  |  DISEASES
85316  |  BAGE5  |  1.085  |  DISEASES
10018  |  BCL2L11  |  1.086  |  DISEASES
8678  |  BECN1  |  1.591  |  DISEASES
648  |  BMI1  |  3.347  |  DISEASES
672  |  BRCA1  |  1.184  |  DISEASES
675  |  BRCA2  |  1.542  |  DISEASES
682  |  BSG  |  3.081  |  DISEASES
685  |  BTC  |  1.036  |  DISEASES
374877  |  C19orf45  |  2.703  |  DISEASES
339883  |  C3orf35  |  1.557  |  DISEASES
768  |  CA9  |  3.282  |  DISEASES
841  |  CASP8  |  2.852  |  DISEASES
842  |  CASP9  |  2.391  |  DISEASES
857  |  CAV1  |  1.764  |  DISEASES
80323  |  CCDC68  |  1.221  |  DISEASES
919  |  CD247  |  1.267  |  DISEASES
29126  |  CD274  |  3.215  |  DISEASES
960  |  CD44  |  4.218  |  DISEASES
961  |  CD47  |  1.224  |  DISEASES
923  |  CD6  |  2.28  |  DISEASES
995  |  CDC25C  |  1.453  |  DISEASES
983  |  CDK1  |  1.24  |  DISEASES
80279  |  CDK5RAP3  |  1.173  |  DISEASES
1029  |  CDKN2A  |  5.538  |  DISEASES
1050  |  CEBPA  |  1.226  |  DISEASES
1063  |  CENPF  |  1.007  |  DISEASES
55165  |  CEP55  |  1.499  |  DISEASES
91012  |  CERS5  |  1.091  |  DISEASES
79094  |  CHAC1  |  1.152  |  DISEASES
1111  |  CHEK1  |  2.008  |  DISEASES
11200  |  CHEK2  |  2.077  |  DISEASES
1364  |  CLDN4  |  1.456  |  DISEASES
1366  |  CLDN7  |  1.171  |  DISEASES
170482  |  CLEC4C  |  1.69  |  DISEASES
1207  |  CLNS1A  |  1.285  |  DISEASES
80781  |  COL18A1  |  1.908  |  DISEASES
1351  |  COX8A  |  1.011  |  DISEASES
1382  |  CRABP2  |  2.316  |  DISEASES
7180  |  CRISP2  |  1.174  |  DISEASES
64478  |  CSMD1  |  1.173  |  DISEASES
1454  |  CSNK1E  |  1.328  |  DISEASES
1485  |  CTAG1B  |  2.067  |  DISEASES
64693  |  CTAGE1  |  2.574  |  DISEASES
1499  |  CTNNB1  |  3.085  |  DISEASES
2017  |  CTTN  |  3.869  |  DISEASES
6387  |  CXCL12  |  2.339  |  DISEASES
9547  |  CXCL14  |  3.236  |  DISEASES
7852  |  CXCR4  |  2.669  |  DISEASES
1543  |  CYP1A1  |  2.349  |  DISEASES
1612  |  DAPK1  |  3.218  |  DISEASES
4921  |  DDR2  |  1.322  |  DISEASES
1719  |  DHFR  |  1.071  |  DISEASES
56616  |  DIABLO  |  1.605  |  DISEASES
373863  |  DND1  |  1.109  |  DISEASES
1789  |  DNMT3B  |  1.467  |  DISEASES
1791  |  DNTT  |  1.994  |  DISEASES
1806  |  DPYD  |  1.017  |  DISEASES
1910  |  EDNRB  |  1.12  |  DISEASES
54583  |  EGLN1  |  1.017  |  DISEASES
10919  |  EHMT2  |  1.252  |  DISEASES
1977  |  EIF4E  |  2.682  |  DISEASES
1978  |  EIF4EBP1  |  1.883  |  DISEASES
1999  |  ELF3  |  1.542  |  DISEASES
79767  |  ELMO3  |  1.587  |  DISEASES
2022  |  ENG  |  1.587  |  DISEASES
953  |  ENTPD1  |  1.754  |  DISEASES
1969  |  EPHA2  |  1.855  |  DISEASES
2045  |  EPHA7  |  1.139  |  DISEASES
2050  |  EPHB4  |  2.627  |  DISEASES
2066  |  ERBB4  |  2.587  |  DISEASES
2068  |  ERCC2  |  1.683  |  DISEASES
2073  |  ERCC5  |  1.209  |  DISEASES
2113  |  ETS1  |  1.398  |  DISEASES
7430  |  EZR  |  1.636  |  DISEASES
51059  |  FAM135B  |  2.036  |  DISEASES
26355  |  FAM162A  |  1.428  |  DISEASES
2175  |  FANCA  |  2.321  |  DISEASES
2188  |  FANCF  |  1.803  |  DISEASES
2189  |  FANCG  |  1.586  |  DISEASES
55120  |  FANCL  |  1.11  |  DISEASES
356  |  FASLG  |  1.897  |  DISEASES
2195  |  FAT1  |  1.629  |  DISEASES
144699  |  FBXL14  |  1.913  |  DISEASES
2214  |  FCGR3A  |  1.787  |  DISEASES
2246  |  FGF1  |  1.788  |  DISEASES
2258  |  FGF13  |  1.306  |  DISEASES
2260  |  FGFR1  |  2.102  |  DISEASES
2261  |  FGFR3  |  1.871  |  DISEASES
2272  |  FHIT  |  2.733  |  DISEASES
2335  |  FN1  |  1.548  |  DISEASES
50943  |  FOXP3  |  2.265  |  DISEASES
55691  |  FRMD4A  |  2.029  |  DISEASES
53940  |  FTHL17  |  1.386  |  DISEASES
8087  |  FXR1  |  1.134  |  DISEASES
104326057  |  GACAT1  |  1.642  |  DISEASES
104797537  |  GACAT3  |  1.568  |  DISEASES
2543  |  GAGE1  |  1.962  |  DISEASES
2576  |  GAGE4  |  1.957  |  DISEASES
8811  |  GALR2  |  3.332  |  DISEASES
2788  |  GNG7  |  2.504  |  DISEASES
2925  |  GRPR  |  1.342  |  DISEASES
2950  |  GSTP1  |  2.7  |  DISEASES
3014  |  H2AFX  |  1.629  |  DISEASES
3039  |  HBA1  |  2.383  |  DISEASES
8925  |  HERC1  |  1.202  |  DISEASES
3091  |  HIF1A  |  3.213  |  DISEASES
8359  |  HIST1H4A  |  1.102  |  DISEASES
8366  |  HIST1H4B  |  1.102  |  DISEASES
8364  |  HIST1H4C  |  1.102  |  DISEASES
8360  |  HIST1H4D  |  1.1  |  DISEASES
8367  |  HIST1H4E  |  1.102  |  DISEASES
8361  |  HIST1H4F  |  1.102  |  DISEASES
8294  |  HIST1H4I  |  1.102  |  DISEASES
8363  |  HIST1H4J  |  1.102  |  DISEASES
8362  |  HIST1H4K  |  1.102  |  DISEASES
8368  |  HIST1H4L  |  1.102  |  DISEASES
8370  |  HIST2H4A  |  1.102  |  DISEASES
554313  |  HIST2H4B  |  1.102  |  DISEASES
121504  |  HIST4H4  |  1.102  |  DISEASES
3105  |  HLA-A  |  1.155  |  DISEASES
3107  |  HLA-C  |  1.322  |  DISEASES
8091  |  HMGA2  |  1.194  |  DISEASES
127540  |  HMGB4  |  1.327  |  DISEASES
51155  |  HN1  |  1.223  |  DISEASES
3190  |  HNRNPK  |  1.228  |  DISEASES
3205  |  HOXA9  |  1.09  |  DISEASES
7923  |  HSD17B8  |  1.602  |  DISEASES
3320  |  HSP90AA1  |  1.662  |  DISEASES
3316  |  HSPB2  |  1.754  |  DISEASES
3428  |  IFI16  |  1.64  |  DISEASES
3440  |  IFNA2  |  1.801  |  DISEASES
3486  |  IGFBP3  |  1.842  |  DISEASES
3551  |  IKBKB  |  1.318  |  DISEASES
3586  |  IL10  |  2.282  |  DISEASES
3621  |  ING1  |  1.915  |  DISEASES
54556  |  ING3  |  4.634  |  DISEASES
51147  |  ING4  |  1.19  |  DISEASES
84289  |  ING5  |  1.8  |  DISEASES
79191  |  IRX3  |  1.803  |  DISEASES
51477  |  ISYNA1  |  1.093  |  DISEASES
3655  |  ITGA6  |  1.675  |  DISEASES
3684  |  ITGAM  |  1.167  |  DISEASES
3713  |  IVL  |  2.59  |  DISEASES
3716  |  JAK1  |  1.591  |  DISEASES
3717  |  JAK2  |  1.422  |  DISEASES
100137047  |  JMJD7  |  2.264  |  DISEASES
3725  |  JUN  |  2.356  |  DISEASES
79831  |  KDM8  |  1.815  |  DISEASES
547  |  KIF1A  |  2.075  |  DISEASES
3836  |  KPNA1  |  1.123  |  DISEASES
11133  |  KPTN  |  1.108  |  DISEASES
3880  |  KRT19  |  2.375  |  DISEASES
3851  |  KRT4  |  2.26  |  DISEASES
388533  |  KRTDAP  |  2.112  |  DISEASES
3916  |  LAMP1  |  1.164  |  DISEASES
10660  |  LBX1  |  1.485  |  DISEASES
84648  |  LCE3D  |  1.509  |  DISEASES
23641  |  LDOC1  |  1.755  |  DISEASES
26468  |  LHX6  |  1.805  |  DISEASES
10288  |  LILRB2  |  1.103  |  DISEASES
728192  |  LINC00460  |  2.703  |  DISEASES
100499467  |  LINC00673  |  1.66  |  DISEASES
91948  |  LINC00923  |  2.703  |  DISEASES
101928687  |  LINC01468  |  2.665  |  DISEASES
100506119  |  LINC01503  |  2.665  |  DISEASES
104355292  |  LINC01525  |  2.665  |  DISEASES
101928770  |  LINC01526  |  2.665  |  DISEASES
101927988  |  LINC01527  |  2.665  |  DISEASES
2846  |  LPAR4  |  1.111  |  DISEASES
4047  |  LSS  |  3.739  |  DISEASES
54742  |  LY6K  |  1.883  |  DISEASES
4100  |  MAGEA1  |  2.404  |  DISEASES
4102  |  MAGEA3  |  2.486  |  DISEASES
4113  |  MAGEB2  |  1.757  |  DISEASES
158809  |  MAGEB6  |  2.39  |  DISEASES
51438  |  MAGEC2  |  2.078  |  DISEASES
728239  |  MAGED4  |  1.049  |  DISEASES
256691  |  MAMDC2  |  1.683  |  DISEASES
5609  |  MAP2K7  |  2.635  |  DISEASES
5599  |  MAPK8  |  1.574  |  DISEASES
23383  |  MAU2  |  4.185  |  DISEASES
4170  |  MCL1  |  2.308  |  DISEASES
4192  |  MDK  |  1.136  |  DISEASES
4193  |  MDM2  |  2.002  |  DISEASES
8076  |  MFAP5  |  1.827  |  DISEASES
100507436  |  MICA  |  1.125  |  DISEASES
10367  |  MICU1  |  1.008  |  DISEASES
326625  |  MMAB  |  1.844  |  DISEASES
4312  |  MMP1  |  2.7  |  DISEASES
4318  |  MMP9  |  3.364  |  DISEASES
4478  |  MSN  |  1.574  |  DISEASES
4513  |  MT-CO2  |  1.15  |  DISEASES
92140  |  MTDH  |  1.885  |  DISEASES
4524  |  MTHFR  |  1.126  |  DISEASES
2475  |  MTOR  |  3.024  |  DISEASES
100463285  |  MTRNR2L4  |  3.748  |  DISEASES
100463289  |  MTRNR2L5  |  3.816  |  DISEASES
100288485  |  MTRNR2L7  |  3.058  |  DISEASES
4582  |  MUC1  |  1.205  |  DISEASES
9961  |  MVP  |  1.565  |  DISEASES
10514  |  MYBBP1A  |  1.195  |  DISEASES
4609  |  MYC  |  2.933  |  DISEASES
100132406  |  NBPF10  |  1.129  |  DISEASES
22916  |  NCBP2  |  1.553  |  DISEASES
51079  |  NDUFA13  |  1.374  |  DISEASES
140609  |  NEK7  |  1.241  |  DISEASES
9221  |  NOLC1  |  1.051  |  DISEASES
4855  |  NOTCH4  |  1.275  |  DISEASES
56944  |  OLFML3  |  2.301  |  DISEASES
390874  |  ONECUT3  |  1.346  |  DISEASES
29943  |  PADI1  |  1.114  |  DISEASES
142  |  PARP1  |  2.653  |  DISEASES
165631  |  PARP15  |  1.222  |  DISEASES
57326  |  PBXIP1  |  1.327  |  DISEASES
102157401  |  PCBP2-OT1  |  1.924  |  DISEASES
5133  |  PDCD1  |  1.966  |  DISEASES
80380  |  PDCD1LG2  |  1.581  |  DISEASES
9659  |  PDE4DIP  |  1.011  |  DISEASES
100169890  |  PEG3-AS1  |  2.703  |  DISEASES
5253  |  PHF2  |  2.588  |  DISEASES
90102  |  PHLDB2  |  1.262  |  DISEASES
118788  |  PIK3AP1  |  1.415  |  DISEASES
100137049  |  PLA2G4B  |  1.659  |  DISEASES
5328  |  PLAU  |  2.664  |  DISEASES
5329  |  PLAUR  |  1.179  |  DISEASES
5366  |  PMAIP1  |  2.007  |  DISEASES
64840  |  PORCN  |  1.116  |  DISEASES
10631  |  POSTN  |  1.443  |  DISEASES
10848  |  PPP1R13L  |  1.172  |  DISEASES
55607  |  PPP1R9A  |  1.417  |  DISEASES
23532  |  PRAME  |  1.551  |  DISEASES
8842  |  PROM1  |  2.372  |  DISEASES
5699  |  PSMB10  |  1.208  |  DISEASES
5728  |  PTEN  |  3.165  |  DISEASES
5738  |  PTGFRN  |  1.202  |  DISEASES
5743  |  PTGS2  |  3.48  |  DISEASES
5744  |  PTHLH  |  1.788  |  DISEASES
5747  |  PTK2  |  1.767  |  DISEASES
2185  |  PTK2B  |  1.292  |  DISEASES
5788  |  PTPRC  |  1.263  |  DISEASES
5789  |  PTPRD  |  1.383  |  DISEASES
5802  |  PTPRS  |  1.487  |  DISEASES
11122  |  PTPRT  |  2.514  |  DISEASES
80223  |  RAB11FIP1  |  1.06  |  DISEASES
57111  |  RAB25  |  1.843  |  DISEASES
84084  |  RAB6C  |  1.629  |  DISEASES
5884  |  RAD17  |  1.211  |  DISEASES
5888  |  RAD51  |  2.325  |  DISEASES
5890  |  RAD51B  |  1.017  |  DISEASES
5915  |  RARB  |  1.843  |  DISEASES
11186  |  RASSF1  |  2.678  |  DISEASES
5962  |  RDX  |  1.703  |  DISEASES
5965  |  RECQL  |  1.66  |  DISEASES
5970  |  RELA  |  2.268  |  DISEASES
5985  |  RFC5  |  1.324  |  DISEASES
387  |  RHOA  |  1.677  |  DISEASES
6091  |  ROBO1  |  1.629  |  DISEASES
9045  |  RPL14  |  1.096  |  DISEASES
6232  |  RPS27  |  2.353  |  DISEASES
6235  |  RPS29  |  1.147  |  DISEASES
58528  |  RRAGD  |  1.461  |  DISEASES
6273  |  S100A2  |  2.103  |  DISEASES
55511  |  SAGE1  |  1.372  |  DISEASES
23098  |  SARM1  |  1.593  |  DISEASES
6336  |  SCN10A  |  1.703  |  DISEASES
7095  |  SEC62  |  1.072  |  DISEASES
5275  |  SERPINB13  |  2.273  |  DISEASES
6318  |  SERPINB4  |  1.93  |  DISEASES
5268  |  SERPINB5  |  1.806  |  DISEASES
6418  |  SET  |  1.268  |  DISEASES
2810  |  SFN  |  1.733  |  DISEASES
6424  |  SFRP4  |  1.137  |  DISEASES
6456  |  SH3GL2  |  2.29  |  DISEASES
652991  |  SKOR2  |  3.706  |  DISEASES
6566  |  SLC16A1  |  1.099  |  DISEASES
9122  |  SLC16A4  |  1.872  |  DISEASES
6513  |  SLC2A1  |  1.867  |  DISEASES
160728  |  SLC5A8  |  2.053  |  DISEASES
6590  |  SLPI  |  1.906  |  DISEASES
4088  |  SMAD3  |  1.564  |  DISEASES
4089  |  SMAD4  |  2.393  |  DISEASES
56916  |  SMARCAD1  |  1.152  |  DISEASES
85027  |  SMIM3  |  1.92  |  DISEASES
23583  |  SMUG1  |  4.858  |  DISEASES
6622  |  SNCA  |  2.281  |  DISEASES
26807  |  SNORD43  |  1.114  |  DISEASES
26806  |  SNORD44  |  1.811  |  DISEASES
6643  |  SNX2  |  1.365  |  DISEASES
6657  |  SOX2  |  3.101  |  DISEASES
11005  |  SPINK5  |  1.053  |  DISEASES
6696  |  SPP1  |  1.37  |  DISEASES
6714  |  SRC  |  3.003  |  DISEASES
6733  |  SRPK2  |  1.052  |  DISEASES
23648  |  SSBP3  |  1.279  |  DISEASES
6759  |  SSX4  |  1.268  |  DISEASES
548313  |  SSX4B  |  1.275  |  DISEASES
6772  |  STAT1  |  2.259  |  DISEASES
6776  |  STAT5A  |  1.429  |  DISEASES
6794  |  STK11  |  1.106  |  DISEASES
56164  |  STK31  |  1.444  |  DISEASES
134957  |  STXBP5  |  1.994  |  DISEASES
10388  |  SYCP2  |  1.431  |  DISEASES
10460  |  TACC3  |  1.022  |  DISEASES
6892  |  TAPBP  |  1.3  |  DISEASES
7029  |  TFDP2  |  1.976  |  DISEASES
7037  |  TFRC  |  1.113  |  DISEASES
7046  |  TGFBR1  |  1.892  |  DISEASES
7053  |  TGM3  |  1.317  |  DISEASES
54106  |  TLR9  |  1.146  |  DISEASES
147138  |  TMC8  |  1.959  |  DISEASES
65062  |  TMEM237  |  1.964  |  DISEASES
7124  |  TNF  |  2.439  |  DISEASES
7127  |  TNFAIP2  |  1.432  |  DISEASES
8784  |  TNFRSF18  |  1.313  |  DISEASES
7158  |  TP53BP1  |  2.523  |  DISEASES
7161  |  TP73  |  1.302  |  DISEASES
9830  |  TRIM14  |  2.423  |  DISEASES
10103  |  TSPAN1  |  1.465  |  DISEASES
85453  |  TSPYL5  |  1.077  |  DISEASES
7422  |  VEGFA  |  3.931  |  DISEASES
7465  |  WEE1  |  1.941  |  DISEASES
7482  |  WNT2B  |  1.161  |  DISEASES
51741  |  WWOX  |  2.89  |  DISEASES
331  |  XIAP  |  1.718  |  DISEASES
7517  |  XRCC3  |  2.571  |  DISEASES
7520  |  XRCC5  |  1.183  |  DISEASES
7525  |  YES1  |  1.027  |  DISEASES
81030  |  ZBP1  |  1.085  |  DISEASES
6935  |  ZEB1  |  1.875  |  DISEASES
124961  |  ZFP3  |  2.022  |  DISEASES
84107  |  ZIC4  |  1.642  |  DISEASES
55954  |  ZMAT5  |  1.271  |  DISEASES
7678  |  ZNF124  |  2.008  |  DISEASES
7561  |  ZNF14  |  2.27  |  DISEASES
90338  |  ZNF160  |  1.863  |  DISEASES
7718  |  ZNF165  |  1.054  |  DISEASES
7739  |  ZNF185  |  1.258  |  DISEASES
7748  |  ZNF195  |  1.693  |  DISEASES
23036  |  ZNF292  |  1.349  |  DISEASES
147923  |  ZNF420  |  2.215  |  DISEASES
80139  |  ZNF703  |  1.705  |  DISEASES
80345  |  ZSCAN16  |  2.046  |  DISEASES
Locus
Symbol | Locus(Total Locus:2)
PTEN  |  10q23.31
ING1  |  13q34
Disease ID 852
Disease squamous cell carcinoma of head and neck
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:1)
HP:0002860  |  Squamous cell carcinoma
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:24)
HP:0002860  |  Squamous cell carcinoma  |  232
HP:0002664  |  Neoplasia  |  94
HP:0030731  |  Carcinoma  |  6
HP:0012740  |  Papilloma  |  3
HP:0001824  |  Weight loss  |  3
HP:0002015  |  Swallowing difficulty  |  2
HP:0000718  |  Aggressive behaviour  |  2
HP:0002835  |  Aspiration  |  2
HP:0100751  |  Esophageal neoplasm  |  2
HP:0000217  |  Dry mouth syndrome  |  2
HP:0002890  |  Thyroid carcinoma  |  1
HP:0012115  |  Liver inflammation  |  1
HP:0002099  |  Asthma  |  1
HP:0200136  |  Oral-pharyngeal dysphagia  |  1
HP:0003002  |  Breast carcinoma  |  1
HP:0009919  |  Retinoblastoma  |  1
HP:0012531  |  Pain  |  1
HP:0000716  |  Depression  |  1
HP:0012378  |  Fatigue  |  1
HP:0100242  |  Sarcoma  |  1
HP:0004326  |  Cachexia  |  1
HP:0011459  |  Esophageal carcinoma  |  1
HP:0030159  |  Cervical polyp  |  1
HP:0001513  |  Obesity  |  1
Disease ID 852
Disease squamous cell carcinoma of head and neck
Manually Symptom(Waiting for update.)
Text Mined Symptom(Waiting for update.)
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:103)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs1042522209350617157TP53umls:C1168401BeFreeStratification analyses showed that a reduced risk associated with the -606CC genotype was more pronounced in subgroups of non-smokers, non-drinkers, younger subjects (defined as ≤57 years), carriers of the TP53 Arg/Arg (rs1042522) genotype, patients with oropharyngeal cancer or late-stage SCCHN.0.1717694532010TP53177676154GT,C
rs1042522242896377157TP53umls:C1168401BeFreeAssociation between p53 Arg72Pro polymorphism and the risk of human papillomavirus-related head and neck squamous cell carcinoma: a meta-analysis.0.1717694532014TP53177676154GT,C
rs104925323271051836CASP3umls:C1168401BeFreeTaken together, our data suggest that the miR-885-5p binding site rs1049253T>C SNP in the 3'-UTR of CASP3 modulates CASP3 expression at both mRNA and protein levels and thus contributes to SCCHN susceptibility.0.0010857672013CASP34184627797AG
rs104925323271051100126334MIR885umls:C1168401BeFreeTaken together, our data suggest that the miR-885-5p binding site rs1049253T>C SNP in the 3'-UTR of CASP3 modulates CASP3 expression at both mRNA and protein levels and thus contributes to SCCHN susceptibility.0.0002714422013CASP34184627797AG
rs1049430257287076456SH3GL2umls:C1168401BeFreeSNP rs1049430 in the 3'-UTR of SH3GL2 regulates its expression: Clinical and prognostic implications in head and neck squamous cell carcinoma.0.0008143262015SH3GL2917796670TG
rs1051266206616496573SLC19A1umls:C1168401BeFreeA80G polymorphism of reduced folate carrier 1 (RFC1) gene and head and neck squamous cell carcinoma etiology in Brazilian population.0.0005428842011SLC19A12145537880TC
rs1052133205719084968OGG1umls:C1168401BeFreeIn conclusion our data showed that the Ser326Cys polymorphism of the OGG1 gene may modify the risk of HNSCC associated with smoking.0.0013572092011OGG1;CAMK139757089CG
rs1052133163810364968OGG1umls:C1168401BeFreeInteraction of OGG1 Ser326Cys polymorphism with cigarette smoking in head and neck squamous cell carcinoma.0.0013572092006OGG1;CAMK139757089CG
rs1052133219861954968OGG1umls:C1168401BeFreeRole of OGG1 Ser326Cys polymorphism and 8-oxoguanine DNA damage in risk assessment of squamous cell carcinoma of head and neck in North Indian population.0.0013572092011OGG1;CAMK139757089CG
rs10735810222421371045CDX2umls:C1168401BeFreeIn a post-hoc analysis of our previous prospective cohort study, VDR polymorphisms including Cdx2 G/A (rs11568820), FokI C/T (rs10735810), BsmI A/G (rs1544410), ApaI G/T (rs7976091), and TaqI T/C (rs731236) were genotyped by sequencing in 204 consecutive patients with HNSCC who underwent tumor resection.0.0002714422011NANANANANA
rs1138272194015262952GSTT1umls:C1168401BeFreeWe hypothesized that GSTM1 null, GSTT1 null, GSTP1 Ile(105)Val, and GSTP1 Ala(114)Val polymorphisms would individually and, more likely, collectively show an association with risk of SPM after index SCCHN.0.0075244282009GSTP11167586108CT
rs11540654242896377157TP53umls:C1168401BeFreeAssociation between p53 Arg72Pro polymorphism and the risk of human papillomavirus-related head and neck squamous cell carcinoma: a meta-analysis.0.1717694532014TP53177676040CT,G,A
rs11549465129199543091HIF1Aumls:C1168401BeFreeWe assessed the difference in transcription activity of two HIF-1alpha polymorphic variants (P582S and A588T), along with molecular epidemiological study among head and neck squamous cell carcinoma (HNSCC) patients.0.0035287442003HIF1A;LOC1053705261461740839CT
rs11549467129199543091HIF1Aumls:C1168401BeFreeWe assessed the difference in transcription activity of two HIF-1alpha polymorphic variants (P582S and A588T), along with molecular epidemiological study among head and neck squamous cell carcinoma (HNSCC) patients.0.0035287442003HIF1A;LOC1053705261461740857GA
rs11568820222421371045CDX2umls:C1168401BeFreeIn a post-hoc analysis of our previous prospective cohort study, VDR polymorphisms including Cdx2 G/A (rs11568820), FokI C/T (rs10735810), BsmI A/G (rs1544410), ApaI G/T (rs7976091), and TaqI T/C (rs731236) were genotyped by sequencing in 204 consecutive patients with HNSCC who underwent tumor resection.0.0002714422011NA1247908762CT
rs1161491320549817406941MIR149umls:C1168401BeFreeThe authors genotyped 4 common polymorphisms in pre-miRNAs: Homo sapiens miRNA 146a (hsa-mir-146a) (reference SNP 2910164 [rs2910164]; guanine to cytosine [G→C]), hsa-mir-149 (rs2292832; guanine to thymine [G→T]), hsa-mir-196a2 (rs11614913; C→T), and hsa-mir-499 (rs3746444; adenine to guanine [A→G]) in 1109 patients with SCCHN (cases) and in 1130 cancer-free patients (controls) in a non-Hispanic white population that was frequency-matched by age and sex.0.0005428842010MIR196A21253991815CT
rs1161491320549817406938MIR146Aumls:C1168401BeFreeThe authors genotyped 4 common polymorphisms in pre-miRNAs: Homo sapiens miRNA 146a (hsa-mir-146a) (reference SNP 2910164 [rs2910164]; guanine to cytosine [G→C]), hsa-mir-149 (rs2292832; guanine to thymine [G→T]), hsa-mir-196a2 (rs11614913; C→T), and hsa-mir-499 (rs3746444; adenine to guanine [A→G]) in 1109 patients with SCCHN (cases) and in 1130 cancer-free patients (controls) in a non-Hispanic white population that was frequency-matched by age and sex.0.0005428842010MIR196A21253991815CT
rs11614913205498175018OXA1Lumls:C1168401BeFreeThe authors genotyped 4 common polymorphisms in pre-miRNAs: Homo sapiens miRNA 146a (hsa-mir-146a) (reference SNP 2910164 [rs2910164]; guanine to cytosine [G→C]), hsa-mir-149 (rs2292832; guanine to thymine [G→T]), hsa-mir-196a2 (rs11614913; C→T), and hsa-mir-499 (rs3746444; adenine to guanine [A→G]) in 1109 patients with SCCHN (cases) and in 1130 cancer-free patients (controls) in a non-Hispanic white population that was frequency-matched by age and sex.0.0002714422010MIR196A21253991815CT
rs121909237NA5728PTENumls:C1168401CLINVARNA0.482985861NAPTEN1087933121CG
rs121909250NA3621ING1umls:C1168401CLINVARNA0.480271442NAING113110719736GC
rs121909251NA3621ING1umls:C1168401CLINVARNA0.480271442NAING113110719739AG
rs121909252NA3621ING1umls:C1168401CLINVARNA0.480271442NAING113110719667CA
rs122998420336794125ADH1Bumls:C1168401BeFreeThe authors conducted a hospital-based study of 1110 patients with squamous cell carcinoma of the head and neck (SCCHN) and a control group of 1129 patients to replicate the associations reported by a recent, large European study between 2 potentially functional single nucleotide polymorphisms (SNPs) of the alcohol dehydrogenase (ADH) genes, a substitution in ADH1B at amino acid 48 from arginine to histidine (R48H) (reference SNP number [rs]1229984; guanine to adenine [G-->A]) and a substitution in ADH7 at amino acid 92 from alanine to glycine (A92G) (rs1573496; cytosine to guanine [C-->G]), and the risk of squamous cell carcinoma of the head and neck (SCCHN).0.0019000932010ADH1B499318162TC
rs12299842033679410327AKR1A1umls:C1168401BeFreeThe authors conducted a hospital-based study of 1110 patients with squamous cell carcinoma of the head and neck (SCCHN) and a control group of 1129 patients to replicate the associations reported by a recent, large European study between 2 potentially functional single nucleotide polymorphisms (SNPs) of the alcohol dehydrogenase (ADH) genes, a substitution in ADH1B at amino acid 48 from arginine to histidine (R48H) (reference SNP number [rs]1229984; guanine to adenine [G-->A]) and a substitution in ADH7 at amino acid 92 from alanine to glycine (A92G) (rs1573496; cytosine to guanine [C-->G]), and the risk of squamous cell carcinoma of the head and neck (SCCHN).0.0010857672010ADH1B499318162TC
rs122998421940907217ALDH2umls:C1168401BeFreeTwo SNPs were associated with SCCHN risk: ADH1B rs1229984 A allele (OR = 0.7; 95% CI, 0.6-0.9) and ALDH2 rs2238151 C allele (OR = 1.2; 95% CI, 1.1-1.4).0.0010857672011ADH1B499318162TC
rs122998421940907125ADH1Bumls:C1168401BeFreeTwo SNPs were associated with SCCHN risk: ADH1B rs1229984 A allele (OR = 0.7; 95% CI, 0.6-0.9) and ALDH2 rs2238151 C allele (OR = 1.2; 95% CI, 1.1-1.4).0.0019000932011ADH1B499318162TC
rs122998420336794551AVPumls:C1168401BeFreeThe authors conducted a hospital-based study of 1110 patients with squamous cell carcinoma of the head and neck (SCCHN) and a control group of 1129 patients to replicate the associations reported by a recent, large European study between 2 potentially functional single nucleotide polymorphisms (SNPs) of the alcohol dehydrogenase (ADH) genes, a substitution in ADH1B at amino acid 48 from arginine to histidine (R48H) (reference SNP number [rs]1229984; guanine to adenine [G-->A]) and a substitution in ADH7 at amino acid 92 from alanine to glycine (A92G) (rs1573496; cytosine to guanine [C-->G]), and the risk of squamous cell carcinoma of the head and neck (SCCHN).0.0013572092010ADH1B499318162TC
rs13181218907462068ERCC2umls:C1168401BeFreeEffects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent.0.0019000932011ERCC2;KLC31945351661TA,G
rs13181214191157515XRCC1umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0057002792011ERCC2;KLC31945351661TA,G
rs1318121890746595CCND1umls:C1168401BeFreeEffects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent.0.0159391262011ERCC2;KLC31945351661TA,G
rs13181214191157517XRCC3umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0021715352011ERCC2;KLC31945351661TA,G
rs13181219452407515XRCC1umls:C1168401BeFreeArg399Gln of XRCC1 appears to have a protective role in people those consume alcohol, while XPD Lys751Gln variants indicated ∼2-fold increased risk of SCCHN in all the co-variate groups.0.0057002792012ERCC2;KLC31945351661TA,G
rs1544410222421371045CDX2umls:C1168401BeFreeIn a post-hoc analysis of our previous prospective cohort study, VDR polymorphisms including Cdx2 G/A (rs11568820), FokI C/T (rs10735810), BsmI A/G (rs1544410), ApaI G/T (rs7976091), and TaqI T/C (rs731236) were genotyped by sequencing in 204 consecutive patients with HNSCC who underwent tumor resection.0.0002714422011VDR;LOC1053697491247846052CT
rs15734962033679410327AKR1A1umls:C1168401BeFreeThe authors conducted a hospital-based study of 1110 patients with squamous cell carcinoma of the head and neck (SCCHN) and a control group of 1129 patients to replicate the associations reported by a recent, large European study between 2 potentially functional single nucleotide polymorphisms (SNPs) of the alcohol dehydrogenase (ADH) genes, a substitution in ADH1B at amino acid 48 from arginine to histidine (R48H) (reference SNP number [rs]1229984; guanine to adenine [G-->A]) and a substitution in ADH7 at amino acid 92 from alanine to glycine (A92G) (rs1573496; cytosine to guanine [C-->G]), and the risk of squamous cell carcinoma of the head and neck (SCCHN).0.0010857672010ADH7499428512CG
rs157349620336794551AVPumls:C1168401BeFreeThe authors conducted a hospital-based study of 1110 patients with squamous cell carcinoma of the head and neck (SCCHN) and a control group of 1129 patients to replicate the associations reported by a recent, large European study between 2 potentially functional single nucleotide polymorphisms (SNPs) of the alcohol dehydrogenase (ADH) genes, a substitution in ADH1B at amino acid 48 from arginine to histidine (R48H) (reference SNP number [rs]1229984; guanine to adenine [G-->A]) and a substitution in ADH7 at amino acid 92 from alanine to glycine (A92G) (rs1573496; cytosine to guanine [C-->G]), and the risk of squamous cell carcinoma of the head and neck (SCCHN).0.0013572092010ADH7499428512CG
rs1573496203367945738PTGFRNumls:C1168401BeFreeThe ADH7 A92G GG and combined CG + GG genotypes were associated with a decreased risk of SCCHN (GG: adjusted OR, 0.32; 95% CI, 0.13-0.82; CG + GG: adjusted OR, 0.74; 95% CI, 0.59-0.94; FPRP, .098) compared with the CC genotype.0.0002714422010ADH7499428512CG
rs157349620336794131ADH7umls:C1168401BeFreeA single nucleotide polymorphism in the alcohol dehydrogenase 7 gene (alanine to glycine substitution at amino acid 92) is associated with the risk of squamous cell carcinoma of the head and neck.0.0002714422010ADH7499428512CG
rs157349620336794125ADH1Bumls:C1168401BeFreeThe authors conducted a hospital-based study of 1110 patients with squamous cell carcinoma of the head and neck (SCCHN) and a control group of 1129 patients to replicate the associations reported by a recent, large European study between 2 potentially functional single nucleotide polymorphisms (SNPs) of the alcohol dehydrogenase (ADH) genes, a substitution in ADH1B at amino acid 48 from arginine to histidine (R48H) (reference SNP number [rs]1229984; guanine to adenine [G-->A]) and a substitution in ADH7 at amino acid 92 from alanine to glycine (A92G) (rs1573496; cytosine to guanine [C-->G]), and the risk of squamous cell carcinoma of the head and neck (SCCHN).0.0019000932010ADH7499428512CG
rs1695194015262950GSTP1umls:C1168401BeFreeThis large prospective cohort study supports a modestly increased risk of SPM after index SCCHN with GSTP1 Ile(105)Val polymorphism and an even greater risk of SPM with multiple combined GST risk genotypes.0.0029858612009GSTP11167585218AG
rs1695194015262952GSTT1umls:C1168401BeFreeWe hypothesized that GSTM1 null, GSTT1 null, GSTP1 Ile(105)Val, and GSTP1 Ala(114)Val polymorphisms would individually and, more likely, collectively show an association with risk of SPM after index SCCHN.0.0075244282009GSTP11167585218AG
rs1695152547632950GSTP1umls:C1168401BeFreeWe hypothesized that head and neck squamous cell carcinoma (HNSCC) might respond differently to chemotherapeutic agents, especially cisplatin (CDDP) because of the presence of GSTP1 I105V polymorphism.0.0029858612004GSTP11167585218AG
rs1799782152528557515XRCC1umls:C1168401BeFreeIn conclusion, the result from our study provides additional evidence of an association of the XRCC1 polymorphism (Arg194Trp) with SCCHN as markers of genetic susceptibility in the Korean population.0.0057002792004XRCC11943553422GA
rs1799782158006787515XRCC1umls:C1168401BeFreeIn this study, two polymorphisms of the XRCC1 gene, Arg194Trp and Arg399Gln were investigated in 95 patients with head and neck carcinoma.0.0057002792005XRCC11943553422GA
rs1799782260113477515XRCC1umls:C1168401BeFreeThe aim of this study was to investigate the association of XRCC1 Arg194Trp and Arg399Gln single nucleotide polymorphisms (SNP), smoking and alcohol consumption with the risk of HNSCC in Turkish population and also to compare to these results with the ones from both Turkish and different populations in the literature.0.0057002792015XRCC11943553422GA
rs1799782214191157517XRCC3umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0021715352011XRCC11943553422GA
rs1799782214191157515XRCC1umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0057002792011XRCC11943553422GA
rs1799782193340532946GSTM2umls:C1168401BeFreeIn addition, the interaction of CYP2E1 (CYP2E1*5B and CYP2E1*6) with other genetic factors (null genotype of glutathione-S-Transferase M1, GSTM1, X-Ray Repair Cross Complementing Group I, XRCC1 (Arg194Trp), and environmental risk factors such as alcohol and tobacco in modifying HNSCC risk were investigated.0.0005428842009XRCC11943553422GA
rs1799793214191157515XRCC1umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0057002792011ERCC21945364001CT
rs1799793214191157517XRCC3umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0021715352011ERCC21945364001CT
rs1801394175962067298TYMSumls:C1168401BeFreeFunctional polymorphisms in genes encoding one-carbon metabolism enzymes, such as methylenetetrahydrofolate reductase (MTHFR C677T and A1298C), methionine synthase (MTR A2756G), methionine synthase reductase (MTRR A66G) and thymidylate synthase (TS), influence folate metabolism and thus might impact on HNSCC risk.0.0013572092007MTRR;FASTKD357870860AG
rs1801394175962064552MTRRumls:C1168401BeFreeNone of the polymorphisms showed any significant impact on HNSCC risk by genotype alone, but we found interactions between drinking habit and MTHFR C667T (P = 0.04), MTR A2756G (P = 0.04) and MTRR A66G (P = 0.03) polymorphisms.0.0005428842007MTRR;FASTKD357870860AG
rs1801394175962064524MTHFRumls:C1168401BeFreeNone of the polymorphisms showed any significant impact on HNSCC risk by genotype alone, but we found interactions between drinking habit and MTHFR C667T (P = 0.04), MTR A2756G (P = 0.04) and MTRR A66G (P = 0.03) polymorphisms.0.0016286512007MTRR;FASTKD357870860AG
rs1801394175962064548MTRumls:C1168401BeFreeNone of the polymorphisms showed any significant impact on HNSCC risk by genotype alone, but we found interactions between drinking habit and MTHFR C667T (P = 0.04), MTR A2756G (P = 0.04) and MTRR A66G (P = 0.03) polymorphisms.0.0008143262007MTRR;FASTKD357870860AG
rs1805087175962064552MTRRumls:C1168401BeFreeNone of the polymorphisms showed any significant impact on HNSCC risk by genotype alone, but we found interactions between drinking habit and MTHFR C667T (P = 0.04), MTR A2756G (P = 0.04) and MTRR A66G (P = 0.03) polymorphisms.0.0005428842007MTR1236885200AG
rs1805087175962067298TYMSumls:C1168401BeFreeFunctional polymorphisms in genes encoding one-carbon metabolism enzymes, such as methylenetetrahydrofolate reductase (MTHFR C677T and A1298C), methionine synthase (MTR A2756G), methionine synthase reductase (MTRR A66G) and thymidylate synthase (TS), influence folate metabolism and thus might impact on HNSCC risk.0.0013572092007MTR1236885200AG
rs1805087175962064548MTRumls:C1168401BeFreeNone of the polymorphisms showed any significant impact on HNSCC risk by genotype alone, but we found interactions between drinking habit and MTHFR C667T (P = 0.04), MTR A2756G (P = 0.04) and MTRR A66G (P = 0.03) polymorphisms.0.0008143262007MTR1236885200AG
rs1805087175962064524MTHFRumls:C1168401BeFreeNone of the polymorphisms showed any significant impact on HNSCC risk by genotype alone, but we found interactions between drinking habit and MTHFR C667T (P = 0.04), MTR A2756G (P = 0.04) and MTRR A66G (P = 0.03) polymorphisms.0.0016286512007MTR1236885200AG
rs1982073203080037040TGFB1umls:C1168401BeFreeWe have recently shown that the single nucleotide polymorphism (SNP) rs1982073 of the TGFbeta1 gene (TGFB1) is associated with the survival of HNSCC patients who have undergone CRT.0.0010857672010NANANANANA
rs2233678200337705300PIN1umls:C1168401BeFreeWe have previously demonstrated an association between a PIN1 promoter variant (-842G>C; rs2233678) and risk of squamous cell carcinoma of the head and neck, a finding supported by additional functional data.0.0005428842010PIN1;LOC100996288199834503GC
rs223815121940907125ADH1Bumls:C1168401BeFreeTwo SNPs were associated with SCCHN risk: ADH1B rs1229984 A allele (OR = 0.7; 95% CI, 0.6-0.9) and ALDH2 rs2238151 C allele (OR = 1.2; 95% CI, 1.1-1.4).0.0019000932011ALDH212111774029TC
rs223815121940907217ALDH2umls:C1168401BeFreeTwo SNPs were associated with SCCHN risk: ADH1B rs1229984 A allele (OR = 0.7; 95% CI, 0.6-0.9) and ALDH2 rs2238151 C allele (OR = 1.2; 95% CI, 1.1-1.4).0.0010857672011ALDH212111774029TC
rs229283220549817406941MIR149umls:C1168401BeFreeThe authors genotyped 4 common polymorphisms in pre-miRNAs: Homo sapiens miRNA 146a (hsa-mir-146a) (reference SNP 2910164 [rs2910164]; guanine to cytosine [G→C]), hsa-mir-149 (rs2292832; guanine to thymine [G→T]), hsa-mir-196a2 (rs11614913; C→T), and hsa-mir-499 (rs3746444; adenine to guanine [A→G]) in 1109 patients with SCCHN (cases) and in 1130 cancer-free patients (controls) in a non-Hispanic white population that was frequency-matched by age and sex.0.0005428842010GPC1;MIR149;PP145712240456086TC
rs229283220549817406938MIR146Aumls:C1168401BeFreeThe authors genotyped 4 common polymorphisms in pre-miRNAs: Homo sapiens miRNA 146a (hsa-mir-146a) (reference SNP 2910164 [rs2910164]; guanine to cytosine [G→C]), hsa-mir-149 (rs2292832; guanine to thymine [G→T]), hsa-mir-196a2 (rs11614913; C→T), and hsa-mir-499 (rs3746444; adenine to guanine [A→G]) in 1109 patients with SCCHN (cases) and in 1130 cancer-free patients (controls) in a non-Hispanic white population that was frequency-matched by age and sex.0.0005428842010GPC1;MIR149;PP145712240456086TC
rs2292832205498175018OXA1Lumls:C1168401BeFreeThe authors genotyped 4 common polymorphisms in pre-miRNAs: Homo sapiens miRNA 146a (hsa-mir-146a) (reference SNP 2910164 [rs2910164]; guanine to cytosine [G→C]), hsa-mir-149 (rs2292832; guanine to thymine [G→T]), hsa-mir-196a2 (rs11614913; C→T), and hsa-mir-499 (rs3746444; adenine to guanine [A→G]) in 1109 patients with SCCHN (cases) and in 1130 cancer-free patients (controls) in a non-Hispanic white population that was frequency-matched by age and sex.0.0002714422010GPC1;MIR149;PP145712240456086TC
rs25487214191157515XRCC1umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0057002792011XRCC11943551574TC
rs25487219452407515XRCC1umls:C1168401BeFreeArg399Gln of XRCC1 appears to have a protective role in people those consume alcohol, while XPD Lys751Gln variants indicated ∼2-fold increased risk of SCCHN in all the co-variate groups.0.0057002792012XRCC11943551574TC
rs25487242050207515XRCC1umls:C1168401BeFreeThe results from this present meta-analysis suggest that XRCC1 Arg399Gln variants may contribute to HNSCC risk among Caucasians and to the risk of larynx squamous cell carcinoma.0.0057002792013XRCC11943551574TC
rs25487158006787515XRCC1umls:C1168401BeFreeIn this study, two polymorphisms of the XRCC1 gene, Arg194Trp and Arg399Gln were investigated in 95 patients with head and neck carcinoma.0.0057002792005XRCC11943551574TC
rs25487260113477515XRCC1umls:C1168401BeFreeThe aim of this study was to investigate the association of XRCC1 Arg194Trp and Arg399Gln single nucleotide polymorphisms (SNP), smoking and alcohol consumption with the risk of HNSCC in Turkish population and also to compare to these results with the ones from both Turkish and different populations in the literature.0.0057002792015XRCC11943551574TC
rs25487214191157517XRCC3umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0021715352011XRCC11943551574TC
rs25489214191157515XRCC1umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0057002792011XRCC11943552260CT,G
rs25489214191157517XRCC3umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0021715352011XRCC11943552260CT,G
rs28929495NA1956EGFRumls:C1168401CLINVARNA0.162616374NAEGFR755174014GA,C,T
rs291016420549817406941MIR149umls:C1168401BeFreeThe authors genotyped 4 common polymorphisms in pre-miRNAs: Homo sapiens miRNA 146a (hsa-mir-146a) (reference SNP 2910164 [rs2910164]; guanine to cytosine [G→C]), hsa-mir-149 (rs2292832; guanine to thymine [G→T]), hsa-mir-196a2 (rs11614913; C→T), and hsa-mir-499 (rs3746444; adenine to guanine [A→G]) in 1109 patients with SCCHN (cases) and in 1130 cancer-free patients (controls) in a non-Hispanic white population that was frequency-matched by age and sex.0.0005428842010LOC285628;MIR146A5160485411CG
rs291016420549817406938MIR146Aumls:C1168401BeFreeThe authors genotyped 4 common polymorphisms in pre-miRNAs: Homo sapiens miRNA 146a (hsa-mir-146a) (reference SNP 2910164 [rs2910164]; guanine to cytosine [G→C]), hsa-mir-149 (rs2292832; guanine to thymine [G→T]), hsa-mir-196a2 (rs11614913; C→T), and hsa-mir-499 (rs3746444; adenine to guanine [A→G]) in 1109 patients with SCCHN (cases) and in 1130 cancer-free patients (controls) in a non-Hispanic white population that was frequency-matched by age and sex.0.0005428842010LOC285628;MIR146A5160485411CG
rs2910164205498175018OXA1Lumls:C1168401BeFreeThe authors genotyped 4 common polymorphisms in pre-miRNAs: Homo sapiens miRNA 146a (hsa-mir-146a) (reference SNP 2910164 [rs2910164]; guanine to cytosine [G→C]), hsa-mir-149 (rs2292832; guanine to thymine [G→T]), hsa-mir-196a2 (rs11614913; C→T), and hsa-mir-499 (rs3746444; adenine to guanine [A→G]) in 1109 patients with SCCHN (cases) and in 1130 cancer-free patients (controls) in a non-Hispanic white population that was frequency-matched by age and sex.0.0002714422010LOC285628;MIR146A5160485411CG
rs374644420549817406938MIR146Aumls:C1168401BeFreeThe authors genotyped 4 common polymorphisms in pre-miRNAs: Homo sapiens miRNA 146a (hsa-mir-146a) (reference SNP 2910164 [rs2910164]; guanine to cytosine [G→C]), hsa-mir-149 (rs2292832; guanine to thymine [G→T]), hsa-mir-196a2 (rs11614913; C→T), and hsa-mir-499 (rs3746444; adenine to guanine [A→G]) in 1109 patients with SCCHN (cases) and in 1130 cancer-free patients (controls) in a non-Hispanic white population that was frequency-matched by age and sex.0.0005428842010MYH7B;MIR499A;MIR499B2034990448AG
rs3746444205498175018OXA1Lumls:C1168401BeFreeThe authors genotyped 4 common polymorphisms in pre-miRNAs: Homo sapiens miRNA 146a (hsa-mir-146a) (reference SNP 2910164 [rs2910164]; guanine to cytosine [G→C]), hsa-mir-149 (rs2292832; guanine to thymine [G→T]), hsa-mir-196a2 (rs11614913; C→T), and hsa-mir-499 (rs3746444; adenine to guanine [A→G]) in 1109 patients with SCCHN (cases) and in 1130 cancer-free patients (controls) in a non-Hispanic white population that was frequency-matched by age and sex.0.0002714422010MYH7B;MIR499A;MIR499B2034990448AG
rs374644420549817406941MIR149umls:C1168401BeFreeThe authors genotyped 4 common polymorphisms in pre-miRNAs: Homo sapiens miRNA 146a (hsa-mir-146a) (reference SNP 2910164 [rs2910164]; guanine to cytosine [G→C]), hsa-mir-149 (rs2292832; guanine to thymine [G→T]), hsa-mir-196a2 (rs11614913; C→T), and hsa-mir-499 (rs3746444; adenine to guanine [A→G]) in 1109 patients with SCCHN (cases) and in 1130 cancer-free patients (controls) in a non-Hispanic white population that was frequency-matched by age and sex.0.0005428842010MYH7B;MIR499A;MIR499B2034990448AG
rs386493716219452407515XRCC1umls:C1168401BeFreeArg399Gln of XRCC1 appears to have a protective role in people those consume alcohol, while XPD Lys751Gln variants indicated ∼2-fold increased risk of SCCHN in all the co-variate groups.0.0057002792012NANANANANA
rs386493716242050207515XRCC1umls:C1168401BeFreeThe results from this present meta-analysis suggest that XRCC1 Arg399Gln variants may contribute to HNSCC risk among Caucasians and to the risk of larynx squamous cell carcinoma.0.0057002792013NANANANANA
rs386493716214191157517XRCC3umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0021715352011NANANANANA
rs386493716260113477515XRCC1umls:C1168401BeFreeThe aim of this study was to investigate the association of XRCC1 Arg194Trp and Arg399Gln single nucleotide polymorphisms (SNP), smoking and alcohol consumption with the risk of HNSCC in Turkish population and also to compare to these results with the ones from both Turkish and different populations in the literature.0.0057002792015NANANANANA
rs386493716158006787515XRCC1umls:C1168401BeFreeIn this study, two polymorphisms of the XRCC1 gene, Arg194Trp and Arg399Gln were investigated in 95 patients with head and neck carcinoma.0.0057002792005NANANANANA
rs386493716214191157515XRCC1umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0057002792011NANANANANA
rs386514057206616496573SLC19A1umls:C1168401BeFreeA80G polymorphism of reduced folate carrier 1 (RFC1) gene and head and neck squamous cell carcinoma etiology in Brazilian population.0.0005428842011NANANANANA
rs386519031129199543091HIF1Aumls:C1168401BeFreeWe assessed the difference in transcription activity of two HIF-1alpha polymorphic variants (P582S and A588T), along with molecular epidemiological study among head and neck squamous cell carcinoma (HNSCC) patients.0.0035287442003NANANANANA
rs386545546152528557515XRCC1umls:C1168401BeFreeIn conclusion, the result from our study provides additional evidence of an association of the XRCC1 polymorphism (Arg194Trp) with SCCHN as markers of genetic susceptibility in the Korean population.0.0057002792004NANANANANA
rs386545546214191157517XRCC3umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0021715352011NANANANANA
rs386545546214191157515XRCC1umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0057002792011NANANANANA
rs386545546158006787515XRCC1umls:C1168401BeFreeIn this study, two polymorphisms of the XRCC1 gene, Arg194Trp and Arg399Gln were investigated in 95 patients with head and neck carcinoma.0.0057002792005NANANANANA
rs386545546193340532946GSTM2umls:C1168401BeFreeIn addition, the interaction of CYP2E1 (CYP2E1*5B and CYP2E1*6) with other genetic factors (null genotype of glutathione-S-Transferase M1, GSTM1, X-Ray Repair Cross Complementing Group I, XRCC1 (Arg194Trp), and environmental risk factors such as alcohol and tobacco in modifying HNSCC risk were investigated.0.0005428842009NANANANANA
rs386545546260113477515XRCC1umls:C1168401BeFreeThe aim of this study was to investigate the association of XRCC1 Arg194Trp and Arg399Gln single nucleotide polymorphisms (SNP), smoking and alcohol consumption with the risk of HNSCC in Turkish population and also to compare to these results with the ones from both Turkish and different populations in the literature.0.0057002792015NANANANANA
rs397507444175962067298TYMSumls:C1168401BeFreeFunctional polymorphisms in genes encoding one-carbon metabolism enzymes, such as methylenetetrahydrofolate reductase (MTHFR C677T and A1298C), methionine synthase (MTR A2756G), methionine synthase reductase (MTRR A66G) and thymidylate synthase (TS), influence folate metabolism and thus might impact on HNSCC risk.0.0013572092007MTHFR111794407TG
rs5443189907632784GNB3umls:C1168401BeFreeThe GNB3 C825T SNP thus represents a host derived prognostic marker in HNSCC, which allows identifying high-risk patients, which could benefit from novel and/or more aggressive therapeutic regimes.0.0002714422008GNB3;CDCA3126845711CT
rs67117033202217ALDH2umls:C1168401BeFreeALDH2 1510 G/A (Glu487Lys) polymorphism interaction with age in head and neck squamous cell carcinoma.0.0010857672006ALDH212111803962GA
rs731236222421371045CDX2umls:C1168401BeFreeIn a post-hoc analysis of our previous prospective cohort study, VDR polymorphisms including Cdx2 G/A (rs11568820), FokI C/T (rs10735810), BsmI A/G (rs1544410), ApaI G/T (rs7976091), and TaqI T/C (rs731236) were genotyped by sequencing in 204 consecutive patients with HNSCC who underwent tumor resection.0.0002714422011VDR;LOC1053697491247844974AG
rs7976091222421371045CDX2umls:C1168401BeFreeIn a post-hoc analysis of our previous prospective cohort study, VDR polymorphisms including Cdx2 G/A (rs11568820), FokI C/T (rs10735810), BsmI A/G (rs1544410), ApaI G/T (rs7976091), and TaqI T/C (rs731236) were genotyped by sequencing in 204 consecutive patients with HNSCC who underwent tumor resection.0.0002714422011NA1247910769CT
rs861539208047475888RAD51umls:C1168401BeFreeIn conclusion our data showed that the C722T and the G135C polymorphisms of the XRCC3 and the RAD51 genes might be associated with HNSCC.0.0016286512010KLC1;XRCC314103699416GA
rs861539208047477517XRCC3umls:C1168401BeFreeIn conclusion our data showed that the C722T and the G135C polymorphisms of the XRCC3 and the RAD51 genes might be associated with HNSCC.0.0021715352010KLC1;XRCC314103699416GA
rs861539214191157515XRCC1umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0057002792011KLC1;XRCC314103699416GA
rs861539214191157517XRCC3umls:C1168401BeFreeGenetic variants ERCC2 Lys751Gln (rs13181), ERCC2 Asp312Asn (rs1799793), XRCC1 Arg194Trp (rs1799782); XRCC1 Gln399Arg (rs25487), XRCC1 Arg280His (rs25489) and XRCC3 Thr241Met (rs861539) were analyzed in a primary study group comprising 169 patients with histologically confirmed HNSCC and 463 healthy control subjects.0.0021715352011KLC1;XRCC314103699416GA
rs9282861165755746817SULT1A1umls:C1168401BeFreeThe purpose of this study was to evaluate whether SULT1A1 Arg213His polymorphisms are risk factors for head and neck squamous cell carcinoma (SCCHN).0.0002714422006SULT1A1;NPIPB81628606193CT
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:1)
HP ID HP Name MP ID MP Name Annotation
HP:0002860Squamous cell carcinomaMP:0011903decreased hematopoietic stem cell proliferationreduction in the expansion rate of a hematopoietic stem cell population by cell division
Mapped by homologous gene(Total Items:1)
HP ID HP Name MP ID MP Name Annotation
HP:0002860Squamous cell carcinomaMP:0013502decreased fibroblast apoptosisreduction in the timing or the number of fibroblast cells undergoing programmed cell death
Disease ID 852
Disease squamous cell carcinoma of head and neck
Case(Waiting for update.)